From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Payment Disclosure
Andrew J. Armstrong
- $5,250
- paid by janssen biotech, a subsidiary of Johnson & Johnson »
- Location: Chapel Hill, N.C.
- Payment for: Fees for Speaker Bureau
- Payment for: Fees for Speaker Bureau
- Reported: Jan. to Dec. 2011 Janssen Biotech
- Search for Andrew J. Armstrong in Prescriber Checkup, our database of prescribing patterns within Medicare's drug program.
Notable drugs produced by janssen biotech include:
- Remicade (plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, Crohn's disease/pediatric Crohn's disease, ankylosing spondylitis, ulcerative colitis/pediatric ulcerative colitis)
- Procrit (anemia, reduction of allogeneic red blood cell transfusions in patients undergoing elective, noncardiac, nonvascular surgery)
- Stelara (plaque psoriasis)
- Simponi (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis)
- Zytiga (prostate cancer)
Important notes
The reports include both the name of the health provider who performed the service and, when reported, the entity paid. They may be different.
Source: Johnson & Johnson. ProPublica last downloaded this record on Dec. 19, 2012.
I think this is my doctor — what should I do?
If your provider is listed, it’s because a drug company reported paying him or her for promotional activities, meals, travel, educational items, consulting or research. Such payments are legal, but research has shown that drug-company marketing can influence what a doctor prescribes. How you can use this data »
Get personalized questions to ask your doctor
Print out this record, along with questions and tips for talking with your physician about drug company payments.
Get checklistWhat Companies Disclose
See which services Johnson & Johnson and other pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.